Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms

Immunology Letters

Volumn 125, Issue 1, 2009, Pages 40-45

  Xiong, Qiyan ^a   Li, Jianping ^a   Jin, Liang ^a   Liu, Jingjing ^a   Li, Taiming ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Heat shock protein 65; Lipids; Nasal; Tolerance

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INJURY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL INTAKE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE; TREATMENT OUTCOME; WILD TYPE;

ADMINISTRATION, INTRANASAL; ANIMALS; ATHEROSCLEROSIS; BACTERIAL PROTEINS; CHAPERONINS; CHOLERA TOXIN; HEAT-SHOCK PROTEINS; IMMUNE TOLERANCE; IMMUNIZATION; LIPIDS; MALE; PEPTIDE FRAGMENTS; RABBITS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 67649989133     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.05.007     Document Type: Article

References (25)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Sherer Y., and Shoenfeld Y. Atherosclerosis. Ann Rheum Dis 61 (2002) 97-99
3. Benagiano M., D'Elios M.M., Amedei A., Azzurri A., van der Zee R., Ciervo A., et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol 174 (2005) 6509-6517
4. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 22 (2002) 1547-1559
5. Im S.H., Barchan D., Fuchs S., and Souroujon M.C. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J Clin Invest 104 (1999) 1667-1668
6. Calder C.J., Nicholson L.B., and Dick A.D. Mechanisms for inducing nasal mucosal tolerance in experimental autoimmune uveoretinitis. Methods 38 (2006) 69-76
7. Harats D., Yacov N., Gilburd B., Shoenfeld Y., and George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 40 (2002) 1333-1338
8. Maron R., Sukhova G., Faria A.M., Hoffmann E., Mach F., Libby P., et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106 (2002) 1708-1715
9. Kowala M.C., Recce R., Beyer S., Gu C., and Valentine M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 149 (2000) 323-330
10. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45 (2004) 1169-1196
11. Xu Q., Dietrich H., Steiner H.J., Gown A.M., Schoel B., Mikuz G., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12 (1992) 789-799
12. Isaka M., Zhao Y., Nobusawa E., Nakajima S., Nakajima K., Yasuda Y., et al. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Microbiol Immunol 52 (2008) 55-63
13. Bublin M., Hoflehner E., Wagner B., Radauer C., Wagner S., Hufnagl K., et al. Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses. Vaccine 25 (2007) 8395-8404
14. Cohen I.R. Thoughts on the pathogenesis of type 1 diabetes and on the arrest of autoimmune beta-cell destruction by peptide p277 vaccination. Isr Med Assoc J 6 (2004) 260-261
15. Finking G., and Hanke H. Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis 135 (1997) 1-7
16. Jin L., Zhu A., Wang Y., Chen Q., Xiong Q., Li J., et al. A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice. J Immunol 180 (2008) 58-63
17. Elias D., and Cohen I.R. The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes 45 (1996) 1168-1172
18. Elias D., Meilin A., Ablamunits V., Birk O.S., Carmi P., Könen-Waisman S., et al. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 46 (1997) 758-764
19. Xu Q., Kleindienst R., Schett G., Waitz W., Jindal S., Gupta R.S., et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 123 (1996) 145-155
20. van Puijvelde G.H., van Es T., van Wanrooij E.J., Habets K.L., de Vos P., van der Zee R., et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007) 2677-2683
21. Kirk E.A., Sutherland P., Wang S.A., Chait A., and LeBoeuf R.C. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128 (1998) 954-959
22. Frostegård J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 (1999) 33-43
23. Brodala N., Merricks E.P., Bellinger D.A., Damrongsri D., Offenbacher S., Beck J., et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 25 (2005) 1446-1451
24. Fabricant C.G., and Fabricant J. Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens. Am Heart J 138 (1999) S465-S468
25. La Flamme A.C., Harvie M., Kenwright D., Cameron K., Rawlence N., Low Y.S., et al. Chronic exposure to schistosome eggs reduces serum cholesterol but has no effect on atherosclerotic lesion development. Parasite Immunol 29 (2007) 259-266